These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19289296)

  • 21. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
    Asahina A; Ishii N; Tohma S
    J Dermatol; 2012 Feb; 39(2):199-201. PubMed ID: 21463364
    [No Abstract]   [Full Text] [Related]  

  • 22. Adalimumab-induced interstitial pneumonia with an improvement of pre-existing rheumatoid arthritis-associated lung involvement.
    Komiya K; Ishii H; Fujita N; Oka H; Iwata A; Sonoda H; Kadota J
    Intern Med; 2011; 50(7):749-51. PubMed ID: 21467710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adalimumab-induced acute pneumonitis in a patient with rheumatoid arthritis.
    Dascalu C; Mrejen-Shakin K; Bandagi S
    J Clin Rheumatol; 2010 Jun; 16(4):172-4. PubMed ID: 20511978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic listeriosis with adalimumab therapy.
    Murphy G; Schmidt-Martin D; Hynes BG; Harney S
    J Clin Rheumatol; 2009 Oct; 15(7):369-70. PubMed ID: 20009978
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Okada SK; Siegel JN
    JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760
    [No Abstract]   [Full Text] [Related]  

  • 26. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
    Gaudin P
    Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
    [No Abstract]   [Full Text] [Related]  

  • 27. Nontuberculous mycobacteria infection and tumor necrosis factor-alpha antagonists.
    Swart RM; van Ingen J; van Soolingen D; Slingerland R; Hendriks WD; den Hollander JG
    Emerg Infect Dis; 2009 Oct; 15(10):1700-1. PubMed ID: 19861085
    [No Abstract]   [Full Text] [Related]  

  • 28. Which TNF inhibitor for rheumatoid arthritis?
    Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
    [No Abstract]   [Full Text] [Related]  

  • 29. [TNF inhibitors for treatment of rheumatoid arthritis].
    Otomo K; Koike T
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2405-12. PubMed ID: 19149036
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of type 1 diabetes mellitus in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor alpha.
    Richez C; Blanco P; Gin H; Schaeverbeke T
    Clin Exp Rheumatol; 2006; 24(5):607. PubMed ID: 17181936
    [No Abstract]   [Full Text] [Related]  

  • 31. CNS demyelination during anti-tumor necrosis factor alpha therapy.
    Bellesi M; Logullo F; Di Bella P; Provinciali L
    J Neurol; 2006 May; 253(5):668-9. PubMed ID: 16311894
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option.
    Abadoglu O; Epozturk K; Atayik E; Kaptanoglu E
    J Investig Allergol Clin Immunol; 2011; 21(4):319-21. PubMed ID: 21721382
    [No Abstract]   [Full Text] [Related]  

  • 33. Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab.
    Wingfield T; Jani M; Krutikov M; Mayer J; Uriel A; Marks J; Ustianowski AP
    Rheumatology (Oxford); 2011 Sep; 50(9):1725-7. PubMed ID: 21700684
    [No Abstract]   [Full Text] [Related]  

  • 34. Knee tuberculosis under rituximab therapy for rheumatoid arthritis.
    Ottaviani S; Tiendrebeogo J; Choudat L; Gill G; Palazzo E; Meyer O; Dieudé P
    Joint Bone Spine; 2013 Jul; 80(4):435-6. PubMed ID: 23238006
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab.
    Diaz JC; Vallejo S; Cañas CA
    Rheumatol Int; 2012 Oct; 32(10):3315-7. PubMed ID: 21881980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adalimumab-associated pulmonary fibrosis reply.
    Huggett MT; Armstrong R
    Rheumatology (Oxford); 2007 Aug; 46(8):1379-80; author reply 1379. PubMed ID: 17553912
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversible T-large granular lymphocyte expansion and neutropenia associated with adalimumab therapy.
    Theodoridou A; Kartsios C; Yiannaki E; Markala D; Settas L
    Rheumatol Int; 2006 Dec; 27(2):201-2. PubMed ID: 16932958
    [No Abstract]   [Full Text] [Related]  

  • 38. [Rituximab in patients with rheumatoid arthritis: systematic review].
    Brodszky V; Czirják L; Géher P; Hodinka L; Kárpáti K; Péntek M; Poór G; Szekanecz Z; Gulácsi L
    Orv Hetil; 2007 Oct; 148(40):1883-93. PubMed ID: 17905683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab.
    Kalyoncu U; Karadag O; Akdogan A; Kisacik B; Erman M; Erguven S; Ertenli AI
    Scand J Infect Dis; 2007; 39(5):475-8. PubMed ID: 17464877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients' groups welcome NICE decisions on arthritis and multiple sclerosis drugs.
    Cole A
    BMJ; 2007 Sep; 335(7617):416-7. PubMed ID: 17762016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.